Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, S. P.
Right arrow Articles by Lange, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, S. P.
Right arrow Articles by Lange, A. J.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 48, Issue 8 1645-1651, Copyright © 1999 by American Diabetes Association

ARTICLES

Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype

SP Miller, GR Anand, EJ Karschnia, GI Bell, DC LaPorte and AJ Lange
Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis 55455, USA.

Glucokinase (GK) is expressed in the pancreatic beta-cells and liver, and plays a key role in the regulation of glucose homeostasis. The enzymatic activity and thermal stability of wild-type (WT) GK and several mutant forms associated with maturity-onset diabetes of the young type 2 (MODY-2) were determined by a steady-state kinetic analysis of the purified expressed proteins. The eight MODY-2 mutations studied were Ala53Ser, Val367Met, Gly80Ala, Thr168Pro, Arg36Trp, Thr209Met, Cys213Arg, and Val226Met. These missense mutations were shown to have variable effects on GK kinetic activity. The Gly80Ala and Thr168Pro mutations resulted in a large decrease in Vmax and a complete loss of the cooperative behavior associated with glucose binding. In addition, the Gly80Ala mutation resulted in a sixfold increase in the half-saturating substrate concentration (S0.5) for ATP, and Thr168Pro resulted in eight- and sixfold increases in the S0.5 values for ATP and glucose, respectively. The Thr209Met and Val226Met mutations exhibited three- and fivefold increases, respectively, in the S0.5 for ATP, whereas the Cys213Arg mutation resulted in a fivefold increase in the S0.5 for glucose. These mutations also led to a small yet significant reduction in Vmax. Of all the mutations studied, only the Cys213Arg mutation had reduced enzymatic activity and decreased thermal stability. Two mutants, Ala53Ser and Val367Met, showed kinetic and thermal stability properties similar to those of WT. These mutants had increased sensitivities to the known negative effectors of GK activity, palmitoyl-CoA, and GK regulatory protein. Taken together, these results illustrate that the MODY-2 phenotype may be linked not only to kinetic alterations but also to the regulation of GK activity.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
C. Arden, A. Trainer, N. de la Iglesia, K. T. Scougall, A. L. Gloyn, A. J. Lange, J. A.M. Shaw, F. M. Matschinsky, and L. Agius
Cell Biology Assessment of Glucokinase Mutations V62M and G72R in Pancreatic {beta}-Cells: Evidence for Cellular Instability of Catalytic Activity
Diabetes, July 1, 2007; 56(7): 1773 - 1782.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. F. Pino, K.-A. Kim, K. D. Shelton, J. Lindner, S. Odili, C. Li, H. W. Collins, M. Shiota, F. M. Matschinsky, and M. A. Magnuson
Glucokinase Thermolability and Hepatic Regulatory Protein Binding Are Essential Factors for Predicting the Blood Glucose Phenotype of Missense Mutations
J. Biol. Chem., May 4, 2007; 282(18): 13906 - 13916.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
M. E Cerf
Transcription factors regulating {beta}-cell function.
Eur. J. Endocrinol., November 1, 2006; 155(5): 671 - 679.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Zhang, C. Li, K. Chen, W. Zhu, X. Shen, and H. Jiang
Conformational transition pathway in the allosteric process of human glucokinase
PNAS, September 5, 2006; 103(36): 13368 - 13373.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
L. E. Fridlyand, L. Ma, and L. H. Philipson
Adenine nucleotide regulation in pancreatic {beta}-cells: modeling of ATP/ADP-Ca2+ interactions
Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E839 - E848.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. S. Remedi, J. C. Koster, B. L. Patton, and C. G. Nichols
ATP-Sensitive K+ Channel Signaling in Glucokinase-Deficient Diabetes
Diabetes, October 1, 2005; 54(10): 2925 - 2931.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. L. Gloyn, S. Odili, D. Zelent, C. Buettger, H. A. J. Castleden, A. M. Steele, A. Stride, C. Shiota, M. A. Magnuson, R. Lorini, et al.
Insights into the Structure and Regulation of Glucokinase from a Novel Mutation (V62M), Which Causes Maturity-onset Diabetes of the Young
J. Biol. Chem., April 8, 2005; 280(14): 14105 - 14113.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. Inoue, Y. Sakuraba, H. Motegi, N. Kubota, H. Toki, J. Matsui, Y. Toyoda, I. Miwa, Y. Terauchi, T. Kadowaki, et al.
A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models generated by a large-scale ENU mutagenesis program
Hum. Mol. Genet., June 1, 2004; 13(11): 1147 - 1157.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Wu, D. A. Okar, A. K. Stoeckman, L.-J. Peng, A. H. Herrera, J. E. Herrera, H. C. Towle, and A. J. Lange
A Potential Role for Fructose-2,6-Bisphosphate in the Stimulation of Hepatic Glucokinase Gene Expression
Endocrinology, February 1, 2004; 145(2): 650 - 658.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
M. J. DUNNE, K. E. COSGROVE, R. M. SHEPHERD, A. AYNSLEY-GREEN, and K. J. LINDLEY
Hyperinsulinism in Infancy: From Basic Science to Clinical Disease
Physiol Rev, January 1, 2004; 84(1): 239 - 275.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
J. Grimsby, R. Sarabu, W. L. Corbett, N.-E. Haynes, F. T. Bizzarro, J. W. Coffey, K. R. Guertin, D. W. Hilliard, R. F. Kester, P. E. Mahaney, et al.
Allosteric Activators of Glucokinase: Potential Role in Diabetes Therapy
Science, July 18, 2003; 301(5631): 370 - 373.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
F. M. Matschinsky
Regulation of Pancreatic {beta}-Cell Glucokinase: From Basics to Therapeutics
Diabetes, December 1, 2002; 51(90003): S394 - 404.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
W. Pratipanawatr, T. Pratipanawatr, K. Cusi, R. Berria, J. M. Adams, C. P. Jenkinson, K. Maezono, R. A. DeFronzo, and L. J. Mandarino
Skeletal Muscle Insulin Resistance in Normoglycemic Subjects With a Strong Family History of Type 2 Diabetes Is Associated With Decreased Insulin-Stimulated Insulin Receptor Substrate-1 Tyrosine Phosphorylation
Diabetes, November 1, 2001; 50(11): 2572 - 2578.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S.-H. Koo, A. K. Dutcher, and H. C. Towle
Glucose and Insulin Function through Two Distinct Transcription Factors to Stimulate Expression of Lipogenic Enzyme Genes in Liver
J. Biol. Chem., March 16, 2001; 276(12): 9437 - 9445.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1999 by the American Diabetes Association.